As Schedule 1 fans rally behind the viral indie game, Drug Dealer Simulator publisher responds to backlash confirming there’s “no lawsuit” – but still a “necessary” investigation
As Schedule 1 fans rally behind the viral indie game, Drug Dealer Simulator publisher responds to backlash confirming there’s “no lawsuit” – but still a “necessary” investigation
